Healthcare Solutions
Looking beyond the ‘magic bullet’ approach to drug discovery
May. 1, 2018—Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.
‘Smart cane’ could one day help flag gait problems, falling risks more quickly
Feb. 12, 2018—Falling is no joke when you're a senior citizen or have other balance issues. Vanderbilt engineers are working on a 'smart cane' that could help physical therapists spot and treat problems sooner.
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.
Study seeks to reduce opioid use for chronic pain
Nov. 30, 2017—Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.
Cell signals that trigger wound healing are surprisingly complex
Oct. 3, 2017—Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.
Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs
Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.
VUSN and VUMC researchers receive FAANP funding for Choosing Wisely collaborative study
Aug. 14, 2017—A collaborative project between Vanderbilt University School of Nursing and Vanderbilt University Medical Center has received funding to pilot a project aimed at demonstrating the influence of nurse practitioners in reducing unnecessary testing.
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
Smart underwear prevents back stress with just a tap
Aug. 1, 2017—"Performance-boosting super suit" hidden under clothing can be activated by a double tap to save users' backs.
How six cups of ground coffee can improve nose, throat surgery
Jun. 20, 2017—Vanderbilt engineers have designed a “granular jamming cap” filled with coffee grounds that can improve the accuracy of the sophisticated “GPS” system that surgeons use for nose and throat surgery.
Risky business
Apr. 5, 2017—Vanderbilt investigators have developed hospital readmission models that may help prevent payment penalties to hospitals when patients are readmitted too soon after discharge.
Vanderbilt investigator lands Stand Up To Cancer grant for “smart” nanoparticles cancer research
Apr. 3, 2017—John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology.
